05.17.22
Johnson & Johnson has appointed Thibaut Mongon as Chief Executive Officer Designate and Paul Ruh as Chief Financial Officer Designate of the future, listed New Consumer Health Company.
As announced last year, the planned separation would create two global businesses – the new Johnson & Johnson and the New Consumer Health Company - that are better positioned to deliver improved health outcomes for patients and consumers through innovation, pursue more targeted business strategies and accelerate growth.
This leadership transition will occur upon completion of the planned separation of the Consumer Health business, expected to occur within 2023. Directors and additional executive leadership appointments will be determined in the coming months as the planned separation process progresses.
Alex Gorsky, executive chairman of Johnson & Johnson commented, “Having worked with both Thibaut and Paul for many years, and, after conducting a thorough external search, I am confident in their collective ability to lead the New Consumer Health Company and its portfolio of iconic brands into the future as a standalone company. I look forward to our continued partnership as the Company continues to work towards the planned separation.”
Joaquin Duato, chief executive officer of Johnson & Johnson added, “In recent years, I’ve seen firsthand the strength and value this team brings to consumers around the world. Whether it is sustainable innovation or digitized ways of working, the Consumer Health business of Johnson & Johnson is on the leading edge of global industry and consumer trends. With Thibaut at the helm, we can expect the New Consumer Health Company to remain mission driven with iconic, science-backed brands and a strong commitment to innovation and remarkable talent. He will be supported by Paul, who brings a strong track record of delivering transformational improvements and who has in-depth knowledge and expertise of the consumer goods industry. I am confident that Thibaut and Paul are the right leaders to deliver significant value for stakeholders.”
Mongon is responsible for leading one of the world’s largest portfolios of consumer health products with trusted brands including Tylenol, Neutrogena, Aveeno, Listerine, and Johnson’s, that improve the personal health of more than one billion consumers at every age and stage of life in more than 100 countries.
Mongon is the driving force behind the strong business momentum and world-class capabilities in the Consumer Health segment. His strategic vision has led to the unlocking of significant value for the business through external partnerships and strategic acquisitions.
Mongon serves on the board of the Consumer Goods Forum. He holds a degree in Business Administration from the KEDGE Bordeaux Business School, a Master of Business Administration from INSEAD and has lived in Europe, Latin America, Asia, and North America.
Ruh holds a Master of Business Administration from the MIT Sloan School of Management and a Bachelor of Science in Engineering from the Universidad Iberoamericana in Mexico City.
As announced last year, the planned separation would create two global businesses – the new Johnson & Johnson and the New Consumer Health Company - that are better positioned to deliver improved health outcomes for patients and consumers through innovation, pursue more targeted business strategies and accelerate growth.
This leadership transition will occur upon completion of the planned separation of the Consumer Health business, expected to occur within 2023. Directors and additional executive leadership appointments will be determined in the coming months as the planned separation process progresses.
Alex Gorsky, executive chairman of Johnson & Johnson commented, “Having worked with both Thibaut and Paul for many years, and, after conducting a thorough external search, I am confident in their collective ability to lead the New Consumer Health Company and its portfolio of iconic brands into the future as a standalone company. I look forward to our continued partnership as the Company continues to work towards the planned separation.”
Joaquin Duato, chief executive officer of Johnson & Johnson added, “In recent years, I’ve seen firsthand the strength and value this team brings to consumers around the world. Whether it is sustainable innovation or digitized ways of working, the Consumer Health business of Johnson & Johnson is on the leading edge of global industry and consumer trends. With Thibaut at the helm, we can expect the New Consumer Health Company to remain mission driven with iconic, science-backed brands and a strong commitment to innovation and remarkable talent. He will be supported by Paul, who brings a strong track record of delivering transformational improvements and who has in-depth knowledge and expertise of the consumer goods industry. I am confident that Thibaut and Paul are the right leaders to deliver significant value for stakeholders.”
About Thibaut Mongon
A business leader with more than 20 years of global experience at Johnson & Johnson, Mongon has served as Executive Vice President and Worldwide Chairman of Consumer Health at Johnson & Johnson since 2019.Mongon is responsible for leading one of the world’s largest portfolios of consumer health products with trusted brands including Tylenol, Neutrogena, Aveeno, Listerine, and Johnson’s, that improve the personal health of more than one billion consumers at every age and stage of life in more than 100 countries.
Mongon is the driving force behind the strong business momentum and world-class capabilities in the Consumer Health segment. His strategic vision has led to the unlocking of significant value for the business through external partnerships and strategic acquisitions.
Mongon serves on the board of the Consumer Goods Forum. He holds a degree in Business Administration from the KEDGE Bordeaux Business School, a Master of Business Administration from INSEAD and has lived in Europe, Latin America, Asia, and North America.
About Paul Ruh
Ruh is a seasoned global financial executive with deep experience in the consumer-packaged goods (CPG) industry. Ruh joined Johnson & Johnson five years ago to become the CFO of the Consumer Health business. He came from PepsiCo, having held the position of CFO of Latin America from 2015 until January 2017. Ruh held several roles in both the Food and the Beverages businesses throughout his 17-year tenure at PepsiCo and has also held previous positions at McKinsey & Company and Procter & Gamble.Ruh holds a Master of Business Administration from the MIT Sloan School of Management and a Bachelor of Science in Engineering from the Universidad Iberoamericana in Mexico City.